2020-2022 Board of Directors and President-elect candidates' profiles

Candidates for the UICC Board of Directors

(listed alphabetically by last name – click on name for full profile)

Candidates for UICC President-elect

Jeff Dunn – Australia

Daiming Fan – China

Gamal Amira – Egypt

Gamal Amira

Gamal Amira
Professor of Surgical Oncology | Immediate President of the EGSSO | President of MISR Cancer Center
NCI Cairo University, Fakkous Center for Cancer and Allied Diseases and MISR Cancer Center

Cairo, Egypt

Why would you like to be on the UICC Board of Directors?

I am delighted to join the UICC Board of Directors. First, I am an initiative in cancer control planning and advanced care. I exerted marvelous efforts throughout my life to help and improve the quality of cancer care in Egypt and the Middle East.

I am a senior member of the Governing Council of INCTR Egypt; I have a previous experience in cancer care and research. Leadership added to my potentials since I led the National Cancer Control Plans and when I first called for the importance establishing and standardization of the cancer care in different districts all over the country.

I dedicated myself for the battle of cancer standing behind healthcare professionals and national societies to work together for our patients.

To date I have improved mentoring many of local stakeholders on cancer-driven strategic planning. As a member of the National Association of Senior Directors, I am a board member of the effective policy making authorities in the country, I am working on a presidential level to help advance and improve the delivery of cancer care for the people of our country.

I am an active committee member of the supreme council of the Ministry of Health as well as the Ministry of Higher Education assigned to evaluate staff performance to achieve business development efforts to facilitate communication among the government and the NGOs for maximum efficiency of the performance of the national cancer control plan.

What makes you a good candidate for the UICC Board of Directors?

I am an experienced and enthusiastic team leader and exceptional interpersonal and motivational abilities. He implemented his knowledge in creating a comfortable atmosphere for cancer care and policy making in the country.

I founded more than eight cancer centers and supervised more than seven other centers dedicated to the care of cancer patients. I am an honorary leader of many national societies and social clubs dedicating most of their activities for the support of cancer patients in different disease areas.

I am the former Head of Surgery Departments of the National Cancer Institute (NCI), Cairo University and Secretary for the Arab Medical Association against Cancer. My success in founding a number of district cancer centers that integrated state-of-the-art medicine with social and educational programs addressing the needs of patients is the capstone of a career with a decidedly international flavor. I am the honorary President of many national societies and social clubs supporting cancer research.

I graduated in 1979 from Cairo University and was trained in surgical oncology in the United States, Europe and Japan, I have received the national First Class Decoration for Science and Art. A member of the Egyptian Parliament for 10 years, I was elected to lead the Egyptian Society of Surgical oncology and MISR Cancer Center for the task of cancer prevention.

Ulrika Årehed Kågström – Sweden

Ulrika Årehed Kågström

Ulrika Årehed Kågström
Secretary General
Cancerfonden/Swedish Cancer Society

Stockholm, Sweden

Why would you like to be on the UICC Board of Directors?

I have served on the UICC Board of Directors since 2018. During this period, we have put more emphasis on the strategic advocacy work and I am chair of the newly established Knowledge, Advocacy and Policy Committee. Political impact, cancer prevention and equal access to cancer care are central to me. I am also a member of the Finance Committee and the Congress and Summit Committee.

My wish is to contribute to the shaping of both vision and strategy for UICC to meet current and future challenges. The consequences of the pandemic of COVID-19 risk being severe for cancer patients and cancer organizations. We need to advance the implementation of existing policies to meet the World Cancer Declaration Targets. UICC can with its great impact and insight on global cancer control play an important role to the implementation of the cancer resolution from 2017. Additionally, we know that 30-50 percent of all cancers can be prevented and UICC has a key role in reinforcing this area.

Through learning and exchanging knowledge and experience with the Board members and colleagues within the UICC network my aim is to identify strategies that continue to make an impact on the global stage in order to maintain an equal cancer care.

The UICC and the Board of Directors has a crucial role in ensuring cancer’s place on the global health agenda and I would be honored to be able to bring together the experiences from different member organizations in order to reduce the global cancer burden.

What makes you a good candidate for the UICC Board of Directors?

Since 2016, I am Secretary General of Cancerfonden, the Swedish Cancer Society – the largest fundraising organization in Sweden. Our core activity is financing research. As Sweden’s largest organizations in the field of cancer, we actively participate in the general debate and have a strong advocacy role. Another task is cancer prevention.

For ten years, I worked for the Swedish Red Cross as Secretary General and previously as Deputy Secretary-General. It provided me with a comprehensive understanding of international work, collaboration and resource mobilization through the Red Cross Red Crescent Movement. It has given me extensive experience in negotiating with governments, financiers, and member associations.

Advocacy is a central part of my work, and I have participated in international work groups covering capacity building, field reviews, global branding, and strategy.

I have an extensive and long-term commitment to performing arts, partly through my previous role as marketing manager and vice president at the Swedish National Theater. Since 2017, I am the chairman of the Royal Dramatic Theater. This has widened my perspectives and deepened my leadership skills in crisis and change management.

As a leader I am often described as calm, open and with an ability to create commitment and stability. This together with my international experience forms a solid foundation to contribute to UICC's international work.

Eric Bouffet – Canada

Eric Bouffet

Eric Bouffet
Director of the Paediatric Neuro-Oncology Program
International Society of Paediatric Oncology and the Hospital for Sick Children, Toronto

Toronto, Canada

Why would you like to be on the UICC Board of Directors?

Fighting cancer - particularly paediatric cancer - has been my lifelong passion. Over the years, I have worked in this field at the national and international level, gaining an international expertise via multiple, global collaborations (e.g. former president of the International Society of Paediatric Oncology - SIOP, member of the Children Oncology Group steering committee, leader of various twinning programs with low- and middle-income countries, lead in charge of training of international oncologists, etc).

I strongly believe that this passion and work align with the goals of the UICC. I would love to contribute my experiences and skills to the UICC’s objectives, particularly those concerning the reduction in premature mortality from non-communicable diseases and fight for equitable access to treatment and care for cancers for all. I am currently chair of the Advocacy Committee of SIOP, which could be a unique opportunity to strengthen the collaboration between these two organisations. In this position, I am also very involved with the WHO Global Initiative of Childhood Cancer. As many countries are transitioning from low to middle income country status, childhood cancer is becoming a priority to be addressed. A lot still needs to be done - even today, one third of children with cancer are not diagnosed. In this context, it is critical to have paediatric voice in the UICC board to advocate for children’s right and specific needs.

What makes you a good candidate for the UICC Board of Directors?

I have worked as an oncologist since 1987. At first, I worked in both the paediatric and adult fields before shifting exclusively to paediatric oncology. In my past 20 years, I have developed a program that has gained a worldwide reputation in research and clinical care for children with brain tumours. As our program grew, I paid special attention to the care of children with brain tumours in low and middle-income countries. In this context, I developed several twinning initiatives in paediatric neuro-oncology, first with Jordan, and then with several countries, including Pakistan, Morocco, Ukraine, Ethiopia, Malaysia and Vietnam. Through these experiences, I was able to witness firsthand the wide diversity in the level of care between different hospitals, regions and continents. In every case, I also got to work with local colleagues to try to optimise the care of their patients. I think that I can bring this knowledge to the UICC and actively contribute to the success of its mission to advance cancer control globally.

Finally, over the past 5 years, I have become increasing involved in international activities - primarily through my presidency of SIOP. In this role, I was given the privilege of representing SIOP at the launch of the Global Initiative for Childhood Cancer during the 73rd UN General Assembly in 09/2018. I believe that this experience and my international connections with paediatric oncologists around the world would be an asset in this position.

Anna Cabanes – United States of America

Anna Cabanes

Anna Cabanes
Global Focus on Cancer

Washington, DC, United States of America

Why would you like to be on the UICC Board of Directors?

With social distancing and other pandemic control measures in place in almost every country, the majority of UICC members have been forced to innovate and adapt to new ways of delivering services and support. Despite the challenges, the shift to digital solutions and a renewed focus on patient-centered services can lead us to get to a better normal. On the UICC’s Board of Directors, I would work hard to assist member organizations in their efforts to continue providing support to cancer patients.

Post-COVID-19, still with potential for future threats, the cancer community will have to unite to avoid losing ground on past gains. UICC is well positioned to push for integration of cancer control in the world health and development agenda, so that where a person lives doesn’t determine whether they live. With a seat on the board, I would work hard to make this happen.

Finally, UICC is building upon its momentum on addressing women’s cancers and, by capitalizing on its experience and broad network, is developing a program to strengthen and engage the global breast cancer community. UICC could leverage my experience in breast cancer advocacy and control in the US, Europe, Africa and Latin America to build capacity for change globally. Serving on UICC’s board, I would help provide increased opportunities for support for UICC members working in the field of breast cancer, extending their reach and impact.

What makes you a good candidate for the UICC Board of Directors?

Passion, expertise and the desire to implement change. I am passionate about UICC’s mission. It shows in the work I have done with UICC: I actively participate in its convening platforms; have served as a mentor for the advocacy program, and volunteer in capacity building activities.

My background is diverse, with strong research and public health training combined with experience in nonprofit management, program implementation, community mobilization and advocacy. In the past 10 years, I have worked on breast cancer from various angles.

As an advisor at Global Focus on Cancer, I am developing support and navigation programs for cancer patients that can be delivered virtually and are accessible to all. Prior to this, I directed global programs at Susan G. Komen, and held positions in cancer research at Georgetown University, and cancer surveillance at the Centro Nacional de Epidemiologia in Spain. A native of Barcelona, I have lived and worked in Halifax, Jerusalem, Madrid, and Washington, DC.

I have worked with advocates, health professionals and governments across the world, including in Brazil, Mexico, Panama, Tanzania, and Zambia, to innovate and integrate cancer programs in healthcare systems. I have seen first-hand the power of patient advocacy in advancing cancer policies and programs, which has led to improvements of cancer survival in parts of the world. I would be honored to bring my expertise to the UICC Board and help achieve these goals everywhere.

Hana Chaar Choueib – Lebanon

Hana Chaar Choueib

Hana Chaar Choueib
General Manager
Children's Cancer Center of Lebanon (CCCL)

Beirut, Lebanon

Why would you like to be on the UICC Board of Directors?

Over the years, the UICC has become a major driver for global cancer control; and we, at the Children’s Cancer Center of Lebanon (CCCL), admire their efforts and are proud of being active members since 2017.

Being on the UICC Board of Directors, I hope to connect with the global cancer community and work jointly on mitigating the anticipated challenges, as well as to make a greater impact on the lives of people living with cancer, especially children, while ensuring access to quality healthcare & treatment through capacity building & convening.

In my role at the CCCL since 2004, I was able to develop our foundation's operation and governance model year after year, acquiring ISO certification in 2008 while ensuring a growing number of patients and increased fundraising nationally & internationally.

Since 2014, I also sit on the Board of Directors of the Children’s Cancer Center of Lebanon (CCCL) UK Limited, a UK-based charity which I initiated with dedicated friends & supporters. This has enabled young cancer patients in Lebanon & the Levant sustainable access to quality treatment & care, as well as advancing the childhood cancer cause across the region.

My most recent contribution to the UICC was at the 2018 World Cancer Congress in Kuala Lumpur, as I was a member of the abstract review committee, presented a session on a CCCL program for refugees, and one of the CCCL projects got shortlisted for the Fundraising Award.

What makes you a good candidate for the UICC Board of Directors?

Through my role and capacities over the years, I have witnessed the positive impact I was able to have on childhood cancer control in Lebanon; and I couldn’t have done it with the empowerment of the Children’s Cancer Center of Lebanon’s (CCCL) Board of Trustees and the efforts and dedication of the CCCL team.

In Lebanon today, all kids with cancer have access to adequate cancer treatment & care where my foundation, the CCCL, supports almost 50% of them. We have also developed several programs to help refugee patients in Lebanon; and increased awareness about childhood cancer through campaigning & multi-sectorial partnerships & collaborations.

Access to adequate cancer treatment still remains a challenge in a lot of places around the world, as was the case in my country Lebanon several years back. My experience in ensuring equitable & efficient access to treatment adds a practical results-based approach to the UICC Board of Directors; in addition to a multi-sectorial & international capability.

Jim Cleary – United States of America

Jim Cleary

Jim Cleary
Professor and Director of Supportive Oncology
Indiana University Simon Cancer Center

Indianapolis, United States of America

Why would you like to be on the UICC Board of Directors?

The World Cancer Declaration convinced me of UICC’s commitment to Palliative Care. Proposed in 2006 and confirmed in Geneva in 2008, it set aspirational 2020 Cancer Control targets. We have a way to go, especially in Palliative Care.

The Declaration included Palliative Care in 2 of its 11 targets.
7. Access to accurate cancer diagnosis, …… palliative care services,……. will have improved for cancer patients in all countries
8. Effective pain control measures, and distress management, will be available to cancer patients in all countries

UICC has addressed these targets enthusiastically. Members and staff have worked with WHO and UN Office of Drugs and Crime in Ghana, Timor-Leste, Congo, and Panama. They worked with professional societies and NGOs (including ESMO, EAPC, IAHPC) on the Global Opioid Policy Initiative. They established the Global Access to Pain Relief Initiative (GAPRI) with the American Cancer Society. UICC has strong voices in support of Palliative care; physicians, nurses, psychologists, supportive care clinicians and cancer society leaders.

UICC needs strong voices for Palliative Care in its ongoing efforts in Cancer Control. Care of cancer patients too often falls by the roadside in the face of competing priorities and other barriers. I commit to be such a voice, working to ensuring balanced access to cancer pain medicines and ensuring the integration of holistic care throughout the cancer journey experienced by increasing individuals worldwide.

What makes you a good candidate for the UICC Board of Directors?

Global Oncology excited me enough in med school to do a summer lymphoma project and a final year elective in Kolkata, India. Oncology training in Adelaide, Australia, had an African influence; my supervisor was Charles Olweny of Uganda, leader of WHO’s 1st essential medicines list for cancer, who educated me in global cancer. This continued at the UW Carbone Cancer Center in Wisconsin, with the center’s worldwide connections.

As the clinical Palliative Care program grew, I became leader of the Wisconsin State Cancer Control Program, leading prevention, screening, treatment efforts and palliative care. In 2008, I became director of the Pain and Policy Studies Group (PPSG), a WHO Collaborating Centre for Pain Policy and Palliative Care, the major player in global access to opioids since 1996. Leadership of PPSG included significant interaction with UICC at the UN CND and WHA as we addressed global inequities in palliative care. I offer these leadership experiences in UICC, working within programs, including the Global Access to Cancer Pain Initiative and on Congress planning committees, as well as participating in the congresses for the last 14 years. I have had leadership committee roles with ASCO and ESMO, served as President of the American Academy of Hospice and Palliative Medicine, and am currently treasurer of the Worldwide Hospice and Palliative Medicine Alliance. I, now a member of the IU Simon Cancer Center, would be honored to serve you on the UICC board.

Daiming Fan – China

Daiming Fan

Daiming Fan
China Anti-Cancer Association

Xi'an, China

Why would you like to be on the UICC Board of Directors?

Over the past decades, the worldwide incidence of cancer has been increasing at the rate of 3%-5% annually. In 2018, China accounted for 30% of these deaths overall and 23.7% of all new cases, with 4.285 million people diagnosed with cancer. Therefore, improving cancer control must be the first priority for us as professionals.

UICC is the world’s leading cancer NGO, with a strong mission dedicated to uniting the cancer community to reduce the global cancer burden, promote greater equity, and integrate cancer control into the world health and development agenda. The World Cancer Declaration launched by UICC has become the strategic plan for global cancer control which provides guidelines for cancer societies from all over the world.

Facing up to the challenge of global cancer burden, as the President of China Anti-Cancer Association, President of Asian Pacific Association of Gastroenterology, member of the Board of Directors of the Union for International Cancer Control, I have the responsibility to commit myself to promote cancer control globally. I aspire to play a critical role in spreading UICC’s vision, taking action on cancer prevention and control to reach the goal of reducing cancer incidence and mortality rates worldwide through serving UICC.

I am willingly to continue working for UICC, to strengthen the capacity of the global cancer health workforce, and to make a difference to cancer control worldwide by providing my expertise and working experiences.

What makes you a good candidate for the UICC Board of Directors?

As the candidate for UICC Board of Directors, I am passionate to contribute to accomplishing the vision of UICC.

I am an oncologist and researcher dedicated to gastrointestinal cancer for over 40 years. I have been working for NGOs as an administrative leader for 20 years, and also served the government by providing public health consultations.

During my presidency of CACA, individual membership has risen from 50,000 to 260,000, professional societies from 49 to 81 and member organizations from 50 to 102. I have actively promoted international collaboration and successfully established relationships with ASCO, AACR, AOS, WGO and other global NGOs. I also launched oversea branches of CACA in Australia, Malaysia, Russia and USA. Under my leadership, CACA has grown into an influential cancer society in China.

As the congress president, I have successfully organized twenty international conferences including the 2013 World Congress of Gastroenterology with over 10,000 participants from 120 countries.

While I have been serving as the Board member of UICC, CACA has been actively involved in UICC programs. Millions from China have participated in World Cancer Day hosted annually by CACA. To promote UICC membership, I have encouraged 20 organizations to enroll in UICC. To expand collaboration, I have engineered CACA’s signing the long-term cooperation Vanguard Program with UICC.

Cristiana Fonseca – Portugal

Cristiana Fonseca

Cristiana Fonseca
Health Education Coordinator
Portuguese League Against Cancer - Northern Branch

Matosinhos, Portugal

Why would you like to be on the UICC Board of Directors?

I work on cancer prevention for more than 20 years now and since the beginning I always got acquainted with UICC and all the projects and materials that were presented European and worldwide level in a huge effort to gather all the organizations towards the same objective: fighting cancer.

This was one of the reasons that I have pointed out two years ago when I was nominated to the Board of Directors which turned out to be impossible to refuse this challenge. I felt it was my time to also contribute to this amazing work and the last two years were truly enlightening. But it wasn't enough time to do all that is needed to do as a representative of the Southern and Mediterrean countries of Europe. I would very much like to have the possibility to be on the UICC Board of Directors again, in order to continue the work, to do more and to do better.

I believe that my experience on cancer prevention and health education, both national and European level, beyond my knowledge concerning tobacco issues and the work with young people would be useful for the future years and challenges in UICC. Finally, I would say that is very important to recognise the past in order to project the future... and I believe I could have this role in UICC Board of Directors.

What makes you a good candidate for the UICC Board of Directors?

I have made my all career on Portuguese League Against Cancer where I joined my degree in Psychology with my practice with informal groups in order to build up a Health Education and Cancer Prevention Programme. Throughout the years I've been assigned several other responsibilities and projects which allowed me to have a pretty good picture concerning all cancer issues beyond prevention such as patients support or capacity building. I've also moved from working on the ground to team management position so I believe that both perspectives are important once in UICC Board of Directors. Besides the work on the regional and national level I've also had the opportunity to represent my institution at European level since the beginning which allowed me to build up strong connections and networks, namely in what concerns tobacco prevention and European code against cancer directives and communications, which could reinforce UICC member and partnership. Being a Portuguese is also a strong point in my favour as representative of south and mediterrean countries in Europe but also because it allows me to communicate with many Portuguese speaking countries (namely in Africa) but also with so many immigrants communities throughout the world. Finally, I think it's very important to UICC Board of Directors to have some continuity and that's what I'll assure if I stay there for two more years.

Nick Grant – United Kingdom

Nick Grant

Nick Grant
Executive Director, Strategic & International Partnerships
Cancer Research UK

London, United Kingdom

Why would you like to be on the UICC Board of Directors?

The next two years will continue to be incredibly challenging for everyone concerned about health. The COVID-19 pandemic has uncovered the deficiencies in our health systems and will lead to a prolonged economic, social and health burden on societies around the world. We cannot afford for cancer to get lost or forgotten in the rush to tackle and then recover from this pandemic.

It has been an honour to have served as a member of the UICC Board for the last four years, playing an increasing role in the governance and activities of the organisation. I have been continually inspired by the work of the organisation and of its members, and by the desire to innovate and continue to grow the ambition. Navigating the next two years will be challenging, but essential. Global unity and collaboration have never been more important, yet they are under challenge as countries and institutions turn inwards. UICC will need to rethink its role and its priorities in an uncertain world, and when so many of its members are under significant financial and operational duress. I am passionate about finding new opportunities for collaboration and finding ways to bring together the exceptional talent and experience that exists in member organisations around the world. The challenge of making this happen in the current environment will be very real, but also highly rewarding.

What makes you a good candidate for the UICC Board of Directors?

As a current Board member, I would look to bring continuity in terms of Board involvement. In the last two years, in addition to contributing to the Board, I have chaired the Partnerships Committee and been a member of the Governance Committee, the Finance, Risk & Audit Committee, and the Summit Steering Group. I am also a member of the McCabe Centre Joint Oversight Committee.

My career has given me experience of commercial and non-profit organisations in a number of sectors, and in over 25 countries – including in international NGOs and different health sectors. At Cancer Research UK, I have broad experience across fundraising, research funding, and policy, and have led our efforts to work more closely with other cancer societies in various parts of the world, including in LMICs. Like many other members, we are now having to revise our plans for the future through uncertainty and significant financial constraints.

UICC has a critical role to play in the coming years – on behalf of its members and the global cancer community. There will be hard choices and trade-offs to make. I hope that my experience, coupled with my knowledge of UICC – its networks, its capabilities and its amazing people – will allow me to play a valuable role in shaping its agenda and its future.

Blair Holladay – United States of America

Blair Holladay

Blair Holladay
Chief Executive Officer (CEO)
American Society for Clinical Pathology (ASCP)

Chicago, United States of America

Why would you like to be on the UICC Board of Directors?

My strengths working with Ministries of Health and Ministries of Education will allow me to assist UICC in expanding its crucial role of relationship building and patient-centric advocacy, especially with policy programs to reduce the global burden of cancer. Throughout my career, I have worked closely with the US National Institutes for Heath, key US cancer advocacy organizations (including the American Cancer Society), and the World Heath Organization as an ardent supporter. As a Scientist, I can provide expertise to UICC for expanding access to capacity building for cancer care, especially in areas of the world in dire need of parity for such programs. As an active lecturer, I can bring solutions-driven testimony and negotiate critical international advocacy control plans. I am also pleased to expand the membership outreach and engage thought leaders to support the mission of UICC, as well as provide financial opportunities for expanding membership. I can expand and engineer a patient-centric advocacy and awareness building portfolio to underscore the crucial role of UICC in international healthcare. The engagement of key thought leaders will help build brand equity of UICC across the globe, and assist UICC with key funding opportunities. Lastly, I’ll vociferously champion universal health coverage, especially for access to care and treatment for cancer and non-communicable diseases.

What makes you a good candidate for the UICC Board of Directors?

Over the course of my 38-year medical career, I have been involved in an extensive array of international outreach within Eastern and Western Europe, Asia, Africa, and Australasia. The majority of my work has focused on providing patients access to care in underserved countries and improving systems in those countries where patients lack essential diagnostic cancer services. In 2005, I expanded the mission of our large non-profit organization to bring personnel credentialing to over 100 countries in order to ensure patient safety/protection of patients. Under my leadership, our organization has built laboratory capacity throughout Africa, Eastern Europe, and Southeast Asia for the President’s Emergency Plan for AIDS Relief by focusing on disease reduction--saving the lives of hundreds of millions. In 2015, I began working directly with the Obama White House (Office for Science and Technology Policy). I was responsible for engineering a critical initiative to bring access to cancer diagnostics and treatment to over 30 countries in Sub-Saharan Africa. This leapfrog technology has provided free services to over a million patients. I have partnered with UICC to promote the original development and expansion of the City Cancer Challenge initiative and have supported UICC educational programs throughout the years (including Congresses/Summits). Lastly, our organization was recently chosen as the host site for the 2021 World Cancer Leaders Summit in Boston.

Dilyara Kaidarova – Kazakhstan

Dilyara Kaidarova

Dilyara Kaidarova
Kazakh Institute of Oncology and Radiology

Almaty, Kazakhstan

Why would you like to be on the UICC Board of Directors?

UICC has proved itself as a powerful and motivating organization, which has a significant impact on the overall development of cancer care globally.

Having joined the UICC over a decade ago as a member, I have been increasingly engaged in its activities, which lead to my participation as an organizer of the World Cancer Leader’s Summit held in Nur-Sultan, Kazakhstan.

Within the last 5 years of my service as a country's Chief Oncologist, Kazakhstan has significantly improved its cancer control landscape. Understanding our country’s healthcare challenges in conditions of limited funding, we developed and adopted the National Comprehensive Cancer Control Plan, which allowed us to attract additional 100 million euros in order to increase financing of all existing services and allocate more budget to such important areas as molecular genetic testing, targeted therapy and immunotherapy drugs, free imaging for patients with suspected cancer, as well as measures to provide access to best cancer care for all. I took the responsibility for the important decision to allocate funding to the construction of new cancer centers in five major regions of Kazakhstan, including the installation of linear accelerators. Kazakhstan is the only country among CIS countries to introduce the nation-wide cancer-screening program fully covered by the State Budget.

I would be honored to apply my best knowledge and experience as a country cancer control leader to the UICC Board of Directors.

What makes you a good candidate for the UICC Board of Directors?

Thanks to my involvement in the work of UICC, I have a clear understanding and full commitment to the aims, principles and values of the UICC. I am dedicated to promotion of a comprehensive approach to cancer care, from prevention and early detection to rehabilitation and palliative care, on the regional level and internationally, with the focus on countries with limited resources.

In 2008, I initiated the "Together Against Cancer" Public Fund with the aim of involving all stratum of the Kazakhstan’s society in the fight against cancer, attract charity to the support of cancer patients, as well as incorporate palliative care in the context of medical care. In 2016, I organized the Kazakh Cancer Society, which joins and leads the efforts of multi-disciplinary teams in every region of the country to promote continuous education, scientific research, efficient management and palliative care programs.

For the past 5 years I’ve been leading the administrative and clinical services of the Kazakh Institute of Oncology and Radiology, which has developed collaborative relations with world’s leading cancer institutions and NGOs.

I believe that my extensive professional and personal relations, as well as longstanding understanding of the developments in the region covering one sixth of Earth's land surface (former Soviet Union) will allow me to contribute to the development of high-standard cancer care services in developing countries and countries with limited resources.

Andrey Kaprin – Russian Federation

Andrey Kaprin

Andrey Kaprin
The Association for Directors of Institutes of Oncology and Radiology, CIS & Eurasia (ADIOR)

Moscow, Russian Federation

Why would you like to be on the UICC Board of Directors?

Priority area of my work as UICC Board of Directors member will be the establishment of strong partnership between UICC and Association for Directors of Institutes of Oncology and Radiology, CIS & Eurasia (ADIOR), which I have the honor to chair. Being the UICC Board of Directors member will allow to represent a professional community of CIS, Eurasia and Eastern Europe countries in decision-making process in the field of cancer control.

Membership in the UICC Board of Directors is also a unique opportunity to share the experience of oncological service in Russia, which celebrates its 75th anniversary this year; carry out joint clinical research and improve methods of diagnosis and treatment of oncological diseases. As chief oncologist of Russia I promote development and implementation of new methods of radiation therapy, proton therapy, brachytherapy, support the development of new radiopharmaceuticals. These are the perspective areas of science cooperation I aim to develop.

I look forward to be included in the work in such areas as healthcare organization, introduction of screening programs and development of perspective technologies of nuclear medicine.

What makes you a good candidate for the UICC Board of Directors?

As healthcare organizer I hold senior positions in healthcare system over past 20 years, now being the director general of the leading oncology cluster in Russia – National Medical Radiology Research Center and elected president of country’s biggest professional community – Association of oncologists of Russia. Chief oncologist of the Russian Federation and Academician of Russian Academy of Sciences.

I have the honor to be elected as President of Association for Directors of Institutes of Oncology and Radiology, CIS & Eurasia (ADIOR) and Vice-President of Central and Eastern European Academy of Oncology, which reflects my long-term and consistent work on the international area. My main goals have always been scientific cooperation beyond politics and borders, joint cross - education and development of new methods of cancer diagnosis and treatment.

I aim to bring my wide experience in oncology service organization and fundamental knowledge of scientist for the benefit of the international cooperation within the UICC framework.

My attitude to work and life could not be better described than in words of brilliant scientist L. Landau: “Everyone has enough strength to live life with dignity. And all this talks about difficult times - this is a clever way to justify inaction, laziness and various sadness. You have to work, and then, you see, times will change."

Anne Lee – Hong Kong

Anne Lee

Anne Lee
Clinical Professor and Head
Department of Clinical Oncology, LKS Faculty of Medicine, The University of Hong Kong

Hong Kong, Hong Kong

Why would you like to be on the UICC Board of Directors?

As a clinical oncologist working at public hospitals for over 40 years, I witnessed substantial improvement in cancer control with advances in medical technology and knowledge. However, there is marked inequity globally, many more lives can be saved if resources and expertise are available. I have also witnessed the tremendous suffering faced by patients with advanced incurable cancer, palliative and psychosocial care are obviously needed. As the Vice Chairman of Hong Kong Anti-Cancer Society, we have been trying to help needy patients and their families, but concerted global efforts can help us to become a stronger and effective advocate.

I have been participating in the development of cancer staging system promulgated by UICC since 2001, as a member of TNM Expert Advisory Panel on Head and Neck Cancers. I was further appointed as the Coordinator of the Global Advisory Group since 2013, advocating universal use of the UICC TNM staging system as the global language for guiding cancer treatment and experience sharing.

I was elected as a member of the UICC Board of Directors since 2016. Together we have been working towards the goal of uniting and supporting the cancer community to reduce the global cancer burden, to promote greater equity, and to ensure cancer control continues to be a world health priority. I earnestly hope that I can contribute more especially in advocating comprehensive cancer plan and universal coverage of essential treatment for all cancer patients.

What makes you a good candidate for the UICC Board of Directors?

As a member of the UICC Board of Directors since 2016, focusing on Capacity Building and Membership, the extensive international networking that I have established will be valuable for enhancing global advocacy movements. As an expert in cancer staging closely connected with UICC for the past 20 years, I can contribute more to continual improvement of the UICC TNM system and prognostic systems, liaise with national staging committee, and represent UICC to present our recommendations at international scientific conferences. As an internationally renowned clinical oncologist and an academic professor, I am well-connected with top international cancer institutes and experts, I can contribute to engage clinical and academic communities for enhancing supports to UICC. I have conducted extensive researches on nasopharyngeal cancer, leading to substantial reduction of the incidence and improvement of survival. Unfortunately there is marked variation in outcome globally, I am now leading a project for International Atomic Energy Agency to study the contributing factors and to improve outcome in developing countries through training and review of radiotherapy plans by international expert. This experience will be useful for developing pragmatic plans by UICC to reduce inequity. As a cancer advocate from an eminent non-government organization in Hong Kong, we have close networking with other organization in Asia, I can help to develop specific programs and promote UICC in the region.

Eun Sook Lee – Republic of Korea

Eun Sook Lee

Eun Sook Lee
National Cancer Center - Korea

Goyang-city, Republic of Korea

Why would you like to be on the UICC Board of Directors?

As the first female President of NCC Korea, I’m eagerly seeking the chance for myself to contribute to world cancer society. I am sure UICC is the best platform for me to achieve the goal in line with its core activities, especially ‘Convening’ and ‘Capacity Building’.

Since 2006, NCCK has remained as a member of UICC. After taking office in 2018, I have ventured into the joint area of work with UICC: sending delegation to the WCC and WCLS, participating in case study and attending COVID-19 teleconference as a panel. In 2019, I have upgraded NCCK as a partner and we are now cooperating to launch the UICC-NCCK Technical Fellowship Program (TF) and bring the Asian Pacific nations’ attention to UICC.

First, to contribute to ‘Convening’, I will encourage ANCCA (Asian National Cancer Centers Alliance) to join UICC. ANCCA consists of 14 NCCs, in which NCCK is the secretariat. We holds tele-meetings quarterly and this will be a good opportunity for UICC to create network with the Asian workforce with my liaison.

Second, to accomplish ‘Capacity Building’, I will develop fellowship program specialized in National Cancer Control Plan (NCCP). With 30 years of successful experience of implementing NCCP, NCCK is ready to work together with whomever wants to. It will cover each area of cancer control including registry, surveillance, prevention and policy making. As a decision-maker of NCCP of Korea, I wish to devote myself into giving insight to the world young professionals.

What makes you a good candidate for the UICC Board of Directors?

As the president of NCCK, I was able to develop my communication skills and build up social networking experiences by participating in events held by WHO and IARC. NCCK has been a WHO collaborating center for cancer control and prevention since 2005 and been cooperating with WHO WPRO (Western Pacific Regional Office). As so far, I have undertaken the collaborative projects such as cancer registry workshop (CanLEAD) every year with WPRO. I attended the 62th IARC Governing Council and presented Korean government’s opinion to the council. In addition, I have promoted an international cancer registry education program called ‘IARC-GICR Summer School’ and kept developing IARC-NCCK master course in our graduate school. I believe these tell my capability of organizing new educational curriculum, considering UICC TF.

Not only did I make those collaborations, I also have hosted more than 20 international conferences since 2018. Furthermore, I successfully led NCCK to sign MoUs with eminent organizations, accomplishing dramatic increase in the number of international MoUs about 280%. In addition, I have brought in the first ICGC-ARGO (International Cancer Genome Consortium) data center in Asia in 2019 while working as the member of Executive Board. I think those points show my personality of not being afraid of initiating new projects and maintaining friendly relation with other organizations, which will bring the momentum to further prosperity of the UICC.

Gilberto Lopes – United States of America

Gilberto Lopes

Gilberto Lopes
Professor of Clinical Medicine, Associate Director for the Cancer Center, Hematology and Medical Oncology Fellowship Director
Sylvester Comprehensive Cancer Center and Miller School of Medicine, University of Miami

Miami, United States of America

Why would you like to be on the UICC Board of Directors?

As a native Brazilian who has lived and worked in Asia, Latin and North America, I have seen first hand the issues that hamper cancer control spanning three continents and settings from low to high income countries, including underserved areas in the latter. These experiences have cemented my conviction that as a united community we can promote greater equity and bring cancer prevention, diagnosis and treatment to the global health and development agendas, reducing the burden of the disease around the world. Cancer has also touched my personal and family life, which moves me to fight the disease with even more tenacity and effort. Over the years, I have developed a network of contacts and friends in governments, civil society, academic and United Nations organizations, which I hope to leverage in supporting UICC's missions and priorities of bringing together the cancer community and world leaders, building capacity to meet regional and national goals, and transforming commitments into local actions.

What makes you a good candidate for the UICC Board of Directors?

I am a practicing physician, and accomplished researcher, educator, administrator, and cancer advocate, as well as a leader in Global Oncology and cancer control. I have closely collaborated with researchers, policy makers and patient advocates around the world. I have run hundreds of clinical trials, which have led to the approval of several anticancer agents, as well as health economics, access and outcomes studies that aimed to inform policy makers and support advocates in increasing access to cancer medications around the world. I have served as an expert to the WHO and the IAEA in official cancer-related missions and I have advised on national cancer control plans in Asia and Latin America. I have served in leadership positions with oncology societies in Singapore, Brazil and the United States, including ASCO’s International Affairs Committee. I have also supported UICC’s missions in several forms. As Editor-in-Chief for the Journal of Global Oncology, a collaboration with UICC, I have led the Journal to become the main outlet for Global Oncology research. I was also co-chair of UICC’s review of the WHO Essential Medicines List for cancer and I have served on the Technical Board of the City Cancer Challenge initiative.

Kenji Lopez Cuevas – Mexico

Kenji Lopez Cuevas

Kenji Lopez Cuevas
Lawyer|Founder and President
Cancer Warriors of Mexico

Mexico City, Mexico

Why would you like to be on the UICC Board of Directors?

The first time I heard the word cancer close to my family was in February 2013 when my mother, Tere, was diagnosed with stage II breast cancer. After she endured a radical mastectomy, I promised her that she would carry on her fight with me at her side. Unfortunately, after a non-stoppable battle, she passed on May 2016. However, I resolved to continue fighting and discovered a specific way to help.

As Founder and President of Cancer Warriors of Mexico, an NGO focused on the defense of cancer patient’s rights, from 2017 to 2019, I conceived and led an initiative before Mexico’s Congress to provide parents of children diagnosed with cancer an occupational leave of up to 364 days with 60% of their income. Moreover, we managed to secure a $20 million dollars annual budget for the implementation of this new and noble right.

COVID-19 threatens cancer patients. Thus, we presented a Bill for the creation of the Solidarity Council for Women with Breast Cancer in Mexico, in order to avoid any budget cuts to the treatment of over 120.000 patients.

With great passion I managed to turn my loss into hope for numerous persons. It also guided me to become a warrior against cancer, turning the law and public policies as weapons against it.

I am strongly convinced that the UICC Board of Directors is the international platform through I could share my experience and expertise in order to further the rights of cancer patients all over the world.

What makes you a good candidate for the UICC Board of Directors?

As a 38 years old Mexican Lawyer who is persistent and passioned I am determined to contribute in increasing the quality of life of cancer patients using my advocate knowledge and international experience.

As Director of Specialized Organizations of the United Nations at the Mexican Ministry of Foreign Affairs, I acquired experience on conducting diplomatic negotiations with representatives of various backgrounds to further humanitarian causes, particularly in 2018 at The Hague.

As President of Cancer Warriors of Mexico, in 2019 we managed to amend three federal laws to provide 9,750 parents with an occupational leave so they could care for their children during their oncological treatments, thus decreasing treatment abandonment up to 70%.

If I have the honor of being elected as member of the UICC Board of Directors, I will propose, according to Article 2.2b of the UICC Constitution, with the guidance of Dr. Anil D'Cruz and the organization’s team, implementing measures pertaining to the use of legal and public policy mechanisms to uphold and advance cancer patient’s rights.

My fight is in memory of those who fought and are no longer with us, for those who survived, for those who are currently fighting and for those of us who, most unfortunately, will have to face the challenge. We are all in this together.

Miriam Mutebi – Kenya

Miriam Mutebi

Miriam Mutebi
Consultant Breast Surgical Oncologist, Clinical epidemiologist & health systems researcher
Aga Khan University Hospital

Nairobi, Kenya

Why would you like to be on the UICC Board of Directors?

As a surgical oncologist practicing in Kenya I am involved in continental, regional and local leadership in cancer control in sub-Saharan Africa (SSA). I am currently the Vice President of East Africa for the African Organization for Research and Training in Cancer (AORTIC) and a member of the Kenya Society for Hematology and Oncology (KESHO) council. Through these positions and in my current role as a UICC regional lead, I have been instrumental in developing international and regional efforts to improve cancer care in East Africa, through symposiums and collaborations that enhance multidisciplinary best practices, such as the 1st and 2nd International breast cancer symposiums, held for the first time in SSA. I have developed and coordinated surgical workforce capacity building initiatives through surgical oncology training courses. Through my work in the African Cancer Coalition (ACC) , we have successfully developed and adapted over 46 resource-stratified guidelines, in partnership with the NCCN and ACS, to harmonize and improve care delivery across SSA.

As a health systems researcher, my focus is on understanding and eliminating barriers to access to care for women with cancers in LMICS. I have also developed initiatives to support women in surgery and oncology. I am invested in value in cancer care and involved in developing care strategies that provide guidance for utilization of available resources such as the AORTIC Choosing Wisely Africa initiative.

What makes you a good candidate for the UICC Board of Directors?

This is a great time to be involved in cancer control. There is an emerging cadre of young oncologists and researchers in sub-Saharan Africa, and cancer care strategies are dynamic and constantly iterating, offering new hopes for many patients. Through my network of international, regional and local colleagues, with a common vision of improving cancer care globally, there are many opportunities to foster peer-to-peer learning and to develop larger global communities of practice and the UICC is the ideal synergistic body for this. I bring a different perspective and expertise in health systems.

There isn’t a one-size fits all approach to addressing disparities in cancer care. I have experience navigating the complexity of implementing cancer control plans. I work well with different teams involved in the diverse aspects of cancer control and have successfully developed sustainable programs. I have participated in the development of cancer policy, screening and prevention strategies and increased community engagement through my training of cancer advocates in Africa. To improve patients’ outcomes, it is critical to find new ways of addressing overlooked patient concerns such as uncertainty, fertility and sexuality as well as the broader concerns of access, equity and justice. I will work hard towards realizing the UICC priorities through enhancing existing efforts and working with cancer control teams to support care in diverse settings.

Ana Cristina Pinho Mendes Pereira – Brazil

Ana Christina Pinho Mendes Pereira

Ana Christina Pinho Mendes Pereira
Director General
INCA - Brazilian National Cancer Institute

Rio de Janeiro, Brazil

Why would you like to be on the UICC Board of Directors?

As the Director General of the Brazilian National Cancer Institute (INCA) for the past four years, I have been able to contribute to improve the quality of care services, research projects and public policies in charge of the Institute, by evoking international collaboration to advance the Institution’s reach and scope of action. In this approach, we have strengthened ties in South-South Cooperation both with Latin America and with Portuguese-speaking countries in Africa, reinforcing the Brazilian commitment towards the 2030 Agenda for SDGs in regard to the NCDs targets. Such actions are aligned to the global effort called upon by the WHO Resolution on Cancer Prevention and Control in the context of an integrated approach. I have been able to further develop my management and leadership skills by facing the great challenge to lead the technical branch of the Ministry of Health working on Cancer Prevention and Control in one of the world's biggest public health system. For the past two years I have had the honor of serving at the UICC Board of Directors, having followed up closely and been able to participate in the important contributions the organization has given towards the strengthening of cancer control worldwide in the challenging times we face. Over the next two years I hope I can contribute to the implementation of the WHO resolution that sets a global strategy for Cervical Cancer Prevention and Control in developing countries.

What makes you a good candidate for the UICC Board of Directors?

I believe my experience acting in different contexts, ranging from care to management, from general health to the broad cancer global context, is surely an asset to contribute to my role in the Board of Directors. I have over 25 years of experience in cancer care and management, including research and teaching positions. As a Physician with specializations in Anesthesiology and Innovative Leadership in Health, I have coordinated the Medical Residency Program in Anesthesiology and have been President of the Rio de Janeiro Society of Anesthesiology, which were opportunities to improve my management and leadership skills. I have broad experience in both private and public health systems, through global and regional collaboration, targeting the improvement of health management and health care innovation. Since 2016 I am Director General of the National Cancer Institute (INCA) in Brazil and of its WHO Collaborating Centre for Tobacco Control, as well as I represent Brazil at the IARC Governing Council, which allowed me to work closely with national and international partners to improve and strengthen cancer control policies in LMICs. Playing an integrative role in numerous international fora and decision-taking instances of global health, I have emphasized the prevention and cancer control goals and stimulated innovative partnerships. I am keen to continue contributing to intercontinental cooperation with UICC members and stakeholders, in order to tackle the global cancer burden.

Philip Poortmans – Belgium

Philip Poortmans

Philip Poortmans
Radiation Oncologist / Professor
Iridium Kankernetwerk & University of Antwerp

Herentals, Belgium

Why would you like to be on the UICC Board of Directors?

All of us involved in prevention, research, diagnosis, treatment and aftercare of cancer are, together with those affected by cancer, partners in a joint effort to defeat cancer!

We are living in exciting times with improvements in our knowledge and understanding of the oncological challenge. However, innovative technology, progressively more targeted pharmaceuticals, surgical and radiation insights are not equally translated from bench to bedside. While these modalities are like instruments, designed to play in harmony in a multidisciplinary philharmonic orchestra, inequalities in access hamper the global population to fully benefit.

To solve all challenges, we need to work closely together to successfully overcome the persistent bad reputation of cancer, reduce economic constraints and tackle limited political long-term visions. All this is required to achieve our objective to improve disease-related outcomes and to give all patients and their families hope, irrespective of who they are and where they live. Europe has an important part to play, with numerous European-wide initiatives underway and with the inequalities issue being very relevant with the East-West European divide.

I want to actively contribute, as a member of this orchestra, to UICC’s mission to “unite and support the cancer community to reduce the global cancer burden, to promote greater equity, and to ensure that cancer control continues to be a priority in the world health and development agenda.”

What makes you a good candidate for the UICC Board of Directors?

Having contributed to the care of patients, research and education, and organisation of oncological healthcare, I can build on a bulk of positive experience. I led change and improvement as medical manager, department head in 2 countries, and President of ECCO and ESTRO. My international connections, my international teaching and my linguistic skills will definitely be an advantage for this position. Multidisciplinarity and patient-centredness are embedded in my genes.

Yes, I have very ambitious views and aims for the organisations I am actively involved in! I would like to, together with the entire UICC Board and staff, further strengthen its role, foster an atmosphere of trust, yes even friendship, within the global field of oncology. UICC will become more than ever a household name for the deployment of political actions, education and science, with multidisciplinary and multi-stakeholder collaboration as the key central theme!

I believe that my candidacy is particularly relevant as my personal skills and competencies, as described in my Curriculum Vitae, allow me to smoothly communicate with the entire community involved in the global oncological working space and given my past international leadership positions. By facilitating mutual understanding and stimulating a frank communication in an open atmosphere wherein all stakeholders feel fully respected and can contribute to their fullest ability, a true unification of forces and efforts will be generated.

C S Pramesh – India

C S Pramesh

C S Pramesh
Director, Tata Memorial Hospital
Tata Memorial Hospital / National Cancer Grid

Mumbai, India

Why would you like to be on the UICC Board of Directors?

The UICC has worked towards cancer control globally by making sure that ministries, societies and member organizations continue to prioritize access to cancer care. It has been a leading voice of patients and patient groups, advocating with governments and policy makers towards measures to decrease the global cancer burden. Much of my work over the past several years has been aligned with this mandate, initially at the level of the largest cancer centre in India, and later at the national level through the National Cancer Grid (NCG) in India, the largest cancer care network in the world. Serving on the Board of Directors of the UICC will provide me a platform to scale up this work at a global level.

My role as the overall coordinator of the NCG provides me with the opportunity to disseminate policies and guidance from the UICC across its 220 member organizations. It also provides me with the perfect platform to extend the scope of the NCG Centre for Global Health amongst other low and middle income countries (LMICs) in Asia, Africa and South America. With cancer incidence in these countries projected to increase exponentially in the next two decades, it is important that barriers to care are recognized and acted upon. My diverse experience (thoracic cancer surgeon, academic position, research, publications, cancer policy) has given me greater appreciation for the importance of overall societal good and the need to address the cancer burden as a global and not a regional issue.

What makes you a good candidate for the UICC Board of Directors?

I will work with the UICC Board and leadership to enhance the UICC’s status and role as the international organisation representing members across the world seeking to improve the lives of those with cancer globally.

I am currently the Director of the Tata Memorial Hospital, the premier cancer centre in India. With strong commitment to patient care, education and research, we are at the forefront of cancer control in the region. I had a major role in initiating and coordinating the National Cancer Grid in India, a large network of 220 cancer centres, research organizations, patient groups, professional societies and NGOs. NCG centres treat over 700,000 new patients with cancer annually (60% of India’s cancer burden). Over the past eight years since inception, I have started several parallel initiatives towards creating uniform standards of cancer care across India.

I have an international perspective, having established relationships and collaborations with many leading organizations in the world including UICC CCan, WHO, King’s College London, Princess Margaret Cancer Centre and others. I have worked closely with governments at state and central level on policy matters including the largest government funded health insurance scheme in the world, the Ayushman Bharat. UICC, being the organisation that brings all stakeholders together from around the world, I will be able to contribute actively to grow the organisation and to work collaboratively with the membership.

Danielle Lee Rodin – Canada

Danielle Lee Rodin

Danielle Lee Rodin
Radiation Oncologist | Director, Global Cancer Program
Princess Margaret Cancer Centre

Toronto, Canada

Why would you like to be on the UICC Board of Directors?

The UICC is a unifying force whose diverse membership and unwavering commitment to global cancer control has placed this issue high on the world health and development agenda. I have been honoured to serve on its Board of Directors as the representative of the UICC Young Leaders. This group is an impressive community of ambassadors that has strengthened UICC’s voice on the global stage. Serving on the Board over the last two years has allowed me to work with its dynamic membership to enhance the impact of UICC for generations to come. I am deeply committed to the aims of UICC and to developing innovative strategies to engage its members, particularly young cancer professionals, in its mission.

As a cancer physician, health policy researcher, and global health advocate, I bring a diverse skillset to the Board to advance UICC’s strategic goals. I have expertise in global health, health economics, and community activism, and my leadership skills were twice recognized with the UICC Young Leader award. This expertise has allowed me to make contributions that add value to the Board and that can guide the development of new and emerging priority areas across the cancer continuum. The need for international cooperation on global health challenges has never been greater and UICC provides an important platform for knowledge exchange. It would be a great honour to continue to contribute UICC’s mission and to work with the outstanding leaders on its Board of Directors.

What makes you a good candidate for the UICC Board of Directors?

My experience in clinical practice, policy, research, and in large international initiatives make me well-equipped to contribute to UICC and its Board of Directors. As the first UICC Young Leader on the Board, I worked with UICC to develop the Young Leader Alumni Programme to ensure that future generations of cancer leaders are engaged in UICC’s work. Continuing to serve on the Board would provide continuity on these and other initiatives and an opportunity to expand them.

I am currently the Director of the Global Cancer Program at Princess Margaret Cancer Centre, where I developed the strategic plan for our global outreach. In this role, I am also collaborating with the Canadian Partnership Against Cancer to increase Canada’s engagement in global cancer control and to support young professionals in this field. Princess Margaret Cancer Centre has a longstanding commitment to UICC and I have personally engaged in its Congresses, Summits, Task Forces, and other advocacy work.

As a practicing oncologist, I understand the frontline challenges in cancer control and, as a health policy researcher, I appreciate the evidence needed to engage health systems. My research on the economics of cancer and on improving access to care has been recognized by WHO and the International Atomic Energy Agency. I would bring this experience to the Board of Directors, along with the perspective of a new generation of leaders and a deep personal and professional commitment to cancer control.

Zainab Shinkafi-Bagudu – Nigeria

Zainab Shinkafi-Bagudu

Zainab Shinkafi-Bagudu
Medicaid Cancer Foundation

Abuja, Nigeria

Why would you like to be on the UICC Board of Directors?

I am passionate about mainstreaming the cancer care continuum via primary healthcare systems in low and middle-income countries; particularly in Sub Saharan Africa. I will dedicate the 2020 – 2022 term to this cause, facilitating the multisectoral approach required to reduce the global cancer burden.

UICC recorded significant successes in advancing its network and goals in the last two years. I have had the privilege of serving on the UICC Board of Directors as the COVID-19 pandemic struck, thanks to its position of strength; UICC rapidly adapted to serve growing needs. I will advance strategies that will increase awareness and access to cancer care services if elected.

The importance of advocacy to UICC’s role in cancer control cannot be overemphasized. We will need to strengthen our engagement with governments, national public health institutions, and policymakers to “ensure that cancer control continues to be a priority in the world health and development agenda." I will bring my wealth of experience to bear on this front.

The COVID-19 pandemic has unfairly impacted cancer patients, gravely exposing cancer care gaps in countries such as Nigeria where even prior to COVID-19, patients travelled significant distances to access services. We need to urgently expand access to UICC’s capacity building programmes. Our existing network of 1050 member organizations and alumni are our greatest asset for this objective.

What makes you a good candidate for the UICC Board of Directors?

I have helped to build several coalitions that advance causes in healthcare, women and child rights, and economic empowerment in Nigeria and Africa. Working with cancer advocates in Nigeria, we have successfully seen to the inclusion of cancer care services on the National Health Insurance Scheme, and a national budget line to fund cancer treatment.

Building a premier medical diagnostic business and working in public service as the first lady of Kebbi State has helped me develop skills in resource mobilization, an ability critical to delivering equitable access to cancer care globally.

Relationships and partnerships with international multilateral financing organizations such as GAVI and the pharmaceutical industry are critical to scaling-up access to screening, vaccination and treatment in LMICs. I lead a cancer foundation that is delivering discount therapies to cancer patients and HPV vaccination to school girls in Nigeria thanks to such partnerships. I will continue to leverage the multilateral relationships that my role in public service affords me to advance access to treatment.

Working through the UICC platform, I facilitated Nigeria’s government signing up to WHO’s global call to action to eliminate cervical cancer. This commitment has translated to action, the Ministry of Health announced that HPV vaccination will be available on the routine immunization schedule from Q1 2021. I am dedicated to such leaps in the cancer care continuum.

Jeff Dunn – Australia (President-elect candidate)

Jeff Dunn

Jeff Dunn AO
Chief Executive Officer
Prostate Cancer Foundation of Australia

Sydney, Australia

1. Why would you like to be UICC President?

Over the past 30 years with the UICC, including the past four as Treasurer and the past six as a Director, I have met with countless patients and their families and have learnt from them of the devastating impact that a cancer diagnosis can have on individuals and communities. Like many, I too, have learnt this lesson through personal experience having cancer diagnosed in my family.

Always, and every day, I have drawn strength from knowing that UICC exists to eliminate this disease, and our efforts make a difference.

My work with UICC has taken me from down under in Australia to the highest villages in the Himalayas, sharing knowledge and building capacity to better prevent and control cancer. I understand from firsthand experience that we can accelerate progress against cancer by more fully engaging the community in our work. I strongly believe that we all have a role to play in cancer control, and that our individual leadership, as members of the UICC, can be a guiding light for action.

Indeed, we have seen tremendous progress over the last three decades, with a 15 per cent improvement in the age- standardized death rate from cancer. At the same time, I know these gains have not been shared equally by all countries.

As a researcher, a behavioural scientist, a health service leader, and a civil society advocate, I am committed to working as part of a global community to drive change towards the realization of the targets World Cancer Declaration.

My motivation to serve the UICC comes from my unshakeable dedication to cancer control, driven by the knowledge that collaboration is key to cancer control. The opportunity to contribute my time and expertise as President of the UICC is a great responsibility and a wonderful challenge to fortify our global work at the local level to save lives.

2. What makes you a good candidate?

My skills, knowledge, and capabilities have been developed through extensive practice in effectively bringing groups together to reduce the burden of cancer on the community.

As a current Board Member and Treasurer of UICC, research leader at the University of Southern Queensland, and a Board Director of one of Australia’s largest Hospital and Health Services, I have developed my understanding by engaging with stakeholders across the continuum of care, working hand-in- hand with community members at the grassroots level, while striving to forge progress through high-level representation to Prime Ministers and policy makers.

Advocacy for patient-centered care has been a focus throughout my career, mobilized by the translation of epidemiological and psycho-oncological research into practice, drawing on unique expertise in supportive care, gained through pioneering research in previously uncharted fields.

My contributions include achieving endorsement from cancer control organisations worldwide of International Quality Standards in Psychosocial Care. Equally, my dedication to enabling the work of civil society has been an enduring feature of my working life, motivated by the desire to bring individuals, communities and health authorities together to work cooperatively towards combatting cancer.

My experience includes collaborating with non-government organisations in low- and middle-income countries to implement regionally specific programs in cancer control. This work has taken me to places such as Nepal, Korea, Taiwan, the Middle East, Africa, Europe and the Americas, broadening my understanding of how cancer uniquely impacts different communities.

My credentials include Board membership on the journal of Psycho-Oncology and Past Presidency of the Asian Pacific Organization for Cancer Prevention. My previous voluntary roles have included service as the Secretary of the International Psycho-oncology Society and Chair of Reach to Recovery International Breast Cancer Support Service.

In addition to my current full-time role as CEO of Prostate Cancer Foundation of Australia, I also serve as Professor and Chair, Social and Behavioral Science, Division of Research and Innovation University of Southern Queensland, where my work has a central focus on the social and behavioral aspects of cancer control, spanning the continuum of research, prevention, early detection, supportive care, and quality of life. I am actively involved in research in this field and also serve as a Director of the West Moreton Hospital and Health Service Board and Chair of the HHS Risk and Audit Committee.

Above all, I am dedicated to applying my international influence to advocate for realization of the World Cancer Declaration, empowering the UICC’s important work with you and others to build global capacity.

3. What are your ambitions for UICC in the future?

Timely, targeted action is key, building on the work of Past Presidents and members to harness our collective capacity and inspire action towards our goal of a 25% reduction in premature mortality worldwide by 2025 and realisation of the WHO Global Strategy for the elimination of cervical cancer.

Achieving this target requires a strong focus, a clear plan, and a commitment to collaborative action.

I will devote my time to addressing the health and wellbeing of our loved ones and the community throughout the life course, to prevent cancer when we can and to support those diagnosed whenever and wherever cancer strikes.

I will dedicate my work to embedding Quality Standards of Care in systems of practice worldwide, recognizing the physical, psychosocial, spiritual and economic impacts of cancer, which have long-lasting effects on individuals and the community, addressing these so that patients and their loved ones can realise optimal quality of life throughout survivorship.

Ultimately, my ambition is to ensure not just that we accelerate the elimination of cancer, but to ensure that those who are living with cancer are living well, worldwide.

Daiming Fan – China (President-elect candidate)

Daiming Fan

Daiming Fan
China Anti-Cancer Association

Beijing, China

1. Why would you like to be UICC President?

I am confident I am the best candidate to serve as the President-elect of UICC. I am passionate about the work of UICC and wish to contribute to the goal of reducing the global burden of cancer by providing my expertise and experiences.

With the worldwide cancer rates increasing at 3-5% annually, and 30% of deaths and 23/7% of all new cases in 2018 being in China, this represents a significant proportion of the global cancer burden. As a professional oncologist improving cancer control is always my first priority and, as a Chinese candidate, I will bring the experience from a significant proportion of the world’s cases to bear on the role.

Facing up to the challenge of global cancer burden, as the President of China Anti-Cancer Association (CACA), President of Asian Pacific Association of Gastroenterology (APAGE), Council member of the World Gastroenterology Organization (WGO) and member of the Board of Directors of the Union for International Cancer Control (UICC), I have the clear duty to commit myself to promoting cancer control globally. I aspire to play a critical role in spreading UICC’s vision, taking action on cancer prevention and control to reach the goal of reducing cancer incidence and mortality rates worldwide through serving UICC.

Since the establishment of UICC in 1933, there has not yet been the opportunity for a Chinese scientist to contribute by serving as UICC President. China accounts for one fifth of the world's annual cancer incidence and a quarter of the mortality. I believe, if I am successfully elected as the UICC President-elect 2020-2022, I will make a difference in global cancer control by uniting the Chinese contribution with cancer communities worldwide, integrating universal resources, strengthening the capacity of the cancer health workforce, and achieving the goal of reducing the global cancer burden.

If I have the chance of working as the UICC President, I will devote myself to improving UICC’s global impact by reducing the cancer burden, increasing equity and improving cancer control worldwide.

2. What makes you a good candidate?

I have strong medical and research background and rich working experiences in serving on NGOs, especially international organizations.

Firstly, I am not only an oncologist, but also a researcher specializing in digestive diseases, particularly gastrointestinal cancer for over 40 years. I have achieved the highest level as an academician of Chinese Academy of Engineering, as well as International membership of the USA National Academy of Medicine. I have obtained numerous prestigious grants and awards including several National Science and Technology Progress Awards: National Hi-tech Research and Development Program of China (863 Program), National Basic Research Program of China (973 Program) and Key Program of National Natural Science Fund, etc. I have won first, second and third-class prizes of National Science and Technology Progress Awards respectively, and a third-class prize of National Technology Invention Awards. I was the first awardee of the Prize “French National Academy of Medicine-Servier” (for work in basic and clinical research of gastric cancer), and have received the 2019 Masters of the WGO Award (in recognition of basic and clinical research of GI cancer). I have authored 31 oncology books as editor-in-chief, published more than 700 peer review articles in international journals, such as Nat Med, Nat Clin Pract Oncol, Lancet and Lancet Gastroenterol & Hepatol., and serves as editor for 13 international medical journals.

As a solidly science based organization, UICC plays a unique and important role in the global cancer and health communities by representing and uniting the world’s major cancer societies, patient groups, policy makers as well as researchers and experts in cancer prevention and control. Thus the President-elect of UICC has a most demanding role. I believe my clinical and research background will contribute to putting greater emphasis on the public health perspective necessary for reducing modifiable risk factors and improving the quality of life of people living with cancer.

Secondly, I am very familiar with the workings of international NGOs as I have been actively working for and organizing them as an administrative leader for 20 years. I have also served the government by providing public health consultations (on gastroenterology and oncology)., I am currently serving as President of the China Anti-Cancer Association (CACA), Asian Pacific Association of Gastroenterology (APAGE), Council member of the World Gastroenterology Organization (WGO) and Member of the Board of Directors of the Union for International Cancer Control (UICC).

During my presidency of CACA, the organization developed to become the most influential cancer society in China and has been awarded the top level of “Building A World Class Association Project” issued by China Association for Science and Technology (CAST). Over the past three years its individual membership has risen from 50,000 to 260,000, professional societies from 49 to 81 and member organizations from 50 to 102. If I serve as President-elect of UICC, I will lead this Chinese powerful team to join and support the development of UICC in a variety of academic and social aspects.

I am an able international collaborator and motivator. I have successfully established relationships with ASCO, AACR, AOS and other global NGOs and also launched oversea branches of CACA in Australia, Malaysia, Russia and USA. As congress president, I have successfully organized twenty international conferences including the 2013 World Congress of Gastroenterology with over 10,000 participants from 120 countries, and several joint meetings on oncology between China and Japan, China and USA, China and France, China and UK, China and Germany, China and Russia, and so on.

I am not only the leader in scientific research institutes, but have also held leadership roles in Chinese government organizations, such as the Vice President of Chinese Academy of Engineering (where I was in charge of medical research) and the Committee Member of the National People’s Congress of China (where I am involved in consulting in the fields of national education, science, culture and health).
While serving as the Board member of UICC 2018-2020, I have facilitated CACA’s active involvement in UICC programs. Millions from China have participated in World Cancer Day hosted annually by CACA for UICC. To promote UICC membership, I have encouraged 20 organizations to enroll in UICC. To expand collaboration, I have engineered CACA’s signing the long-term cooperation Vanguard Program with UICC.

3. What are your ambitions for UICC in the future?

If I serve as President-elect of UICC, my first priority is to further enlarge the membership of UICC by encouraging more cancer organizations, partners, patients groups and policy makers from all over the world to join. This will increase its ability to developing cancer control plans, and further extend UICC’s wide-reaching impact on global cancer control.

Secondly I will improve the academic level of UICC, by integrating Western and Traditional Chinese medicine, translating basic research into clinic practice, and applying advances in technology for early detection and prevention of cancer. I will promote networking among world-class scientists facilitating collaboration and combination of medical resources to serve cancer patients worldwide. If I am successfully elected as the President-elect of UICC, I am confident that I will improve global cancer prevention, treatment and research and make a different in cancer control.

Thirdly, I will increase UICC’s financial support by enrolling many more strategic partners to join the Patrons and Champions Programs, to provide a strong fund raising base for UICC. I have proven ability in this area for as President of WCG in 2013, I, engaged in fund-raising for WGO, WEO, and APAGE and enabled four NGOs to have sufficient funds to support academic activities.

Fourthly I will strive to improve the overall level of global cancer control by assisting countries with less medical rescores and poor facilities for cancer prevention, detection, treatment and research by providing medical expertise and financial support. I will raise the profile of cancer control with all policy makers to ensure they address this as the priority task to reach the goal of increasing worldwide equity in cancer control.

I expect that through my serving UICC, cancer will become a central consideration in all national health plans. The resulting increased investment in prevention, early detection, treatment and care, will result in a lowering of cancer incidence and mortality worldwide, particularly in low and middle-income countries.

I am willingly to work for UICC as the President-elect; I sincerely hope that UICC colleagues will provide me with the unique opportunity to make my contribution to the world’s leading cancer NGO, and to reach our common goal of making a difference to cancer control worldwide.

The information contained in each of the candidates' profile has been provided by the candidates themselves, and it is intended exclusively for the UICC members voting at the elections for the UICC Board of Directors and President-elect. UICC's role is limited to providing the platform for the candidates to share their information and views. The views expressed by the candidates are not those of UICC.  Any use, disclosure or unauthorised reproduction of this information is prohibited. 

Last update: 
Thursday 6 August 2020